HMOX1 and neoplasm: Andersen and colleagues conducted a study whose results showed that immunosuppressive HO-1-specific CD8+ regulatory T cells were found in patients tumor tissues and peripheral blood, hence the HO-1 intrinsic immunosuppressive activity which could be studied as target for therapeutic intervention through immunomodulation [182].